𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Metabolic syndrome and higher risk of maternal placental syndromes and cardiovascular disease

✍ Scribed by Joel G. Ray

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
168 KB
Volume
67
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Maternal placental syndromes (MPS), including the hypertensive disorders of pregnancy and abruption or infarction of the placenta, likely originate from diseased placental vessels. MPS is more common in women who exhibit the metabolic syndrome and classic risk factors for cardiovascular disease, including obesity, pre‐pregnancy hypertension, diabetes mellitus, and dyslipidemia. The link between the MPS and premature cardiovascular disease is likely mediated by a woman's metabolic syndrome profile, thus providing an early opportunity for the prevention of cardiovascular disease in women through dietary and lifestyle modifications. Drug Dev. Res. 67:607–611, 2006. Β© 2006 Wiley‐Liss, Inc.

πŸ“œ SIMILAR VOLUMES

The metabolic syndrome and risk of incid
The metabolic syndrome and risk of incident colorectal cancer
✍ Rehana L. Ahmed; Kathryn H. Schmitz; Kristin E. Anderson; Wayne D. Rosamond; Aar πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 139 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The authors tested the hypothesis that the metabolic syndrome (β‰₯3 of the following components: high blood pressure, increased waist circumference, hypertriglyceridemia, low levels of high‐density lipoprotein cholesterol, or diabetes/hyperglycemia) is a risk factor for col

Metabolic syndrome and risk of bladder c
Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can)
✍ Christel HΓ€ggstrΓΆm; Tanja Stocks; Kilian Rapp; Tone BjΓΈrge; BjΓΆrn Lindkvist; Han πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 156 KB πŸ‘ 1 views

## Abstract There are little data on the putative association between factors in the metabolic syndrome (MetS) and risk of bladder cancer. In the Metabolic Syndrome and Cancer project (Me‐Can), measurements of height, weight, blood pressure and circulating levels of glucose, cholesterol, and trigly